For example, 14% of HCC patients were with CTNNB1 mutations and most were missense mutations, however, the composition of TP53 mutations among the 14% mutated HCC patients were more diverse, in frame and frame shift mutations also contributed heavily in addition to missense mutation (Figure 1F). This evidence concerns the gene TP53 and hepatocellular carcinoma.